» Articles » PMID: 26161049

Complementary and Alternative Drug Therapy Versus Science-oriented Medicine

Overview
Journal Ger Med Sci
Specialty General Medicine
Date 2015 Jul 11
PMID 26161049
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

This opinion deals critically with the so-called complementary and alternative medical (CAM) therapy on the basis of current data. From the authors' perspective, CAM prescriptions and most notably the extensive current endeavours to the "integration" of CAM into conventional patient care is problematic in several respects. Thus, several CAM measures are used, although no specific effects of medicines can be proved in clinical studies. It is extensively explained that the methods used in this regard are those of evidence-based medicine, which is one of the indispensable pillars of science-oriented medicine. This standard of proof of efficacy is fundamentally independent of the requirement of being able to explain efficacy of a therapy in a manner compatible with the insights of the natural sciences, which is also essential for medical progress. Numerous CAM treatments can however never conceivably satisfy this requirement; rather they are justified with pre-scientific or unscientific paradigms. The high attractiveness of CAM measures evidenced in patients and many doctors is based on a combination of positive expectations and experiences, among other things, which are at times unjustified, at times thoroughly justified, from a science-oriented view, but which are non-specific (context effects). With a view to the latter phenomenon, the authors consider the conscious use of CAM as unrevealed therapeutic placebos to be problematic. In addition, they advocate that academic medicine should again systematically endeavour to pay more attention to medical empathy and use context effects in the service of patients to the utmost. The subsequent opinion discusses the following after an introduction to medical history: the definition of CAM; the efficacy of most common CAM procedures; CAM utilisation and costs in Germany; characteristics of science-oriented medicine; awareness of placebo research; pro and contra arguments about the use of CAM, not least of all in terms of aspects related to medical ethics.

Citing Articles

How does the role of complementary and alternative medicine in general practice differ between countries? Interviews with doctors who have worked both in Germany and elsewhere in Europe.

Linde K, Bayer R, Gehrmann J, Jansky B BMC Complement Med Ther. 2024; 24(1):328.

PMID: 39227930 PMC: 11373194. DOI: 10.1186/s12906-024-04624-w.


Medical decision making beyond evidence: Correlates of belief in complementary and alternative medicine (CAM) and homeopathy.

Assmann L, Betsch T PLoS One. 2023; 18(4):e0284383.

PMID: 37083856 PMC: 10121010. DOI: 10.1371/journal.pone.0284383.


Use of complementary and alternative therapies by patients with eye diseases: a hospital-based cross-sectional study from Palestine.

Jaber D, Ghannam R, Rashed W, Shehadeh M, Zyoud S BMC Complement Med Ther. 2021; 21(1):3.

PMID: 33397355 PMC: 7784325. DOI: 10.1186/s12906-020-03188-9.


Complementary medicine use by community-dwelling older Australians.

Lefevre A, Hopper I, McNeil J, Owen A Med J Aust. 2020; 214(3):140-141.

PMID: 33305398 PMC: 8754473. DOI: 10.5694/mja2.50884.


Types of Medication-Assisted Treatment for Opioid Use Disorder in Turkey: The Perceptions of Inpatients about Treatment Success.

Erk M, Firat S Psychiatry Investig. 2020; 17(12):1182-1190.

PMID: 33301668 PMC: 8560342. DOI: 10.30773/pi.2020.0307.


References
1.
Ernst E . Homeopathy, non-specific effects and good medicine. Rheumatology (Oxford). 2010; 50(6):1007-8. DOI: 10.1093/rheumatology/keq265. View

2.
Ernst E . A systematic review of systematic reviews of homeopathy. Br J Clin Pharmacol. 2002; 54(6):577-82. PMC: 1874503. DOI: 10.1046/j.1365-2125.2002.01699.x. View

3.
Amanzio M, Pollo A, Maggi G, Benedetti F . Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001; 90(3):205-215. DOI: 10.1016/S0304-3959(00)00486-3. View

4.
Hrobjartsson A, Norup M . The use of placebo interventions in medical practice--a national questionnaire survey of Danish clinicians. Eval Health Prof. 2003; 26(2):153-65. DOI: 10.1177/0163278703026002002. View

5.
Marschall U, Arnold B, Hauser W . [Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009]. Schmerz. 2011; 25(4):402-4, 406-10. DOI: 10.1007/s00482-011-1079-3. View